Literature DB >> 33234362

Enhanced protein degradation by intracellular delivery of pre-fused PROTACs using lipid-like nanoparticles.

Jinjin Chen1, Min Qiu1, Feihe Ma1, Liu Yang1, Zachary Glass1, Qiaobing Xu2.   

Abstract

Proteolysis-targeting chimaera (PROTAC) technology is an emerging approach for achieving targeted degradation of a protein of interest (POI) intracellularly. However, the cell permeability of PROTACs is limited by their high molecular weight and total polar surface area. Moreover, the activation of the proteasome-mediated degradation by PROTAC requires the formation of a ternary (three-component) complex, composed of the PROTAC, the POIs, and E3-ligases related proteins (E3Ps). Simplifying the three-component system to two-component system could theoretically increase the efficiency of the formation of ternary complex and enhance the protein degradation efficiency. Herein, we demonstrate that pre-fusion of PROTACs with E3Ps (called "pre-fused PROTACs") before administration could transform the original PROTAC system to two-component system. After delivery by lipid nanoparticles, the degradation of POI by pre-fused PROTACs was dramatically increased and accelerated compared with standard PROTACs. Moreover, we demonstrated that this approach could be generalized to another hydrophobic tag (HyT) degrader by demonstrating the improved targeted protein degradation after pre-fusion the HyT degrader with heat shock protein 70 (HSP70).
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug delivery; Lipid-like nanoparticle (LNP); PROTAC; Protein degradation

Mesh:

Substances:

Year:  2020        PMID: 33234362      PMCID: PMC7906926          DOI: 10.1016/j.jconrel.2020.11.032

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

Review 1.  Small-Molecule PROTACS: New Approaches to Protein Degradation.

Authors:  Momar Toure; Craig M Crews
Journal:  Angew Chem Int Ed Engl       Date:  2016-01-12       Impact factor: 15.336

2.  PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer.

Authors:  Kanak Raina; Jing Lu; Yimin Qian; Martha Altieri; Deborah Gordon; Ann Marie K Rossi; Jing Wang; Xin Chen; Hanqing Dong; Kam Siu; James D Winkler; Andrew P Crew; Craig M Crews; Kevin G Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

Review 3.  Proteolysis-Targeting Chimeras: Induced Protein Degradation as a Therapeutic Strategy.

Authors:  Philipp Ottis; Craig M Crews
Journal:  ACS Chem Biol       Date:  2017-03-20       Impact factor: 5.100

4.  Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles.

Authors:  Ming Wang; John A Zuris; Fantao Meng; Holly Rees; Shuo Sun; Pu Deng; Yong Han; Xue Gao; Dimitra Pouli; Qi Wu; Irene Georgakoudi; David R Liu; Qiaobing Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

5.  A comprehensive mathematical model for three-body binding equilibria.

Authors:  Eugene F Douglass; Chad J Miller; Gerson Sparer; Harold Shapiro; David A Spiegel
Journal:  J Am Chem Soc       Date:  2013-04-16       Impact factor: 15.419

6.  Theranostic dendrimer-based lipid nanoparticles containing PEGylated BODIPY dyes for tumor imaging and systemic mRNA delivery in vivo.

Authors:  Hu Xiong; Shuai Liu; Tuo Wei; Qiang Cheng; Daniel J Siegwart
Journal:  J Control Release       Date:  2020-07-03       Impact factor: 9.776

7.  Catalytic in vivo protein knockdown by small-molecule PROTACs.

Authors:  Daniel P Bondeson; Alina Mares; Ian E D Smith; Eunhwa Ko; Sebastien Campos; Afjal H Miah; Katie E Mulholland; Natasha Routly; Dennis L Buckley; Jeffrey L Gustafson; Nico Zinn; Paola Grandi; Satoko Shimamura; Giovanna Bergamini; Maria Faelth-Savitski; Marcus Bantscheff; Carly Cox; Deborah A Gordon; Ryan R Willard; John J Flanagan; Linda N Casillas; Bartholomew J Votta; Willem den Besten; Kristoffer Famm; Laurens Kruidenier; Paul S Carter; John D Harling; Ian Churcher; Craig M Crews
Journal:  Nat Chem Biol       Date:  2015-06-10       Impact factor: 15.040

8.  Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging.

Authors:  Jeffrey L Gustafson; Taavi K Neklesa; Carly S Cox; Anke G Roth; Dennis L Buckley; Hyun Seop Tae; Thomas B Sundberg; D Blake Stagg; John Hines; Donald P McDonnell; John D Norris; Craig M Crews
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-17       Impact factor: 15.336

9.  ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice.

Authors:  Qiyue Wang; Virender Kumar; Feng Lin; Bharti Sethi; Donald W Coulter; Timothy R McGuire; Ram I Mahato
Journal:  J Control Release       Date:  2020-05-05       Impact factor: 9.776

View more
  6 in total

Review 1.  PROTACs: great opportunities for academia and industry (an update from 2020 to 2021).

Authors:  Ming He; Chaoguo Cao; Zhihao Ni; Yongbo Liu; Peilu Song; Shuang Hao; Yuna He; Xiuyun Sun; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2022-06-09

Review 2.  Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation.

Authors:  Yu Chen; Ira Tandon; William Heelan; Yixin Wang; Weiping Tang; Quanyin Hu
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

Review 3.  Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs.

Authors:  Yamin Li; Zhongfeng Ye; Hanyi Yang; Qiaobing Xu
Journal:  Acta Pharm Sin B       Date:  2022-04-27       Impact factor: 14.903

4.  Coiled coil exposure and histidine tags drive function of an intracellular protein drug carrier.

Authors:  Anshul Dhankher; Wei Lv; William T Studstill; Julie A Champion
Journal:  J Control Release       Date:  2021-09-24       Impact factor: 9.776

5.  Targeted Protein Degradation: An Important Tool for Drug Discovery for "Undruggable" Tumor Transcription Factors.

Authors:  Mengyuan Dai; Sridhar Radhakrishnan; Rui Li; Ruirong Tan; Kuo Yan; Gang Fan; Miao Liu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 6.  Small-Molecule PROTACs for Cancer Immunotherapy.

Authors:  Zefan Liu; Yajun Zhang; Yucheng Xiang; Xin Kang
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.